Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
Nano Letters2011Vol. 12(1), pp. 287–292
Citations Over TimeTop 10% of 2011 papers
Warefta Hasan, Kevin S. Chu, Anuradha Gullapalli, Stuart S. Dunn, Elizabeth M. Enlow, J. Christopher Luft, Shaomin Tian, Mary E. Napier, Patrick D. Pohlhaus, Jason P. Rolland, Joseph M. DeSimone
Abstract
Nanotechnology can provide a critical advantage in developing strategies for cancer management and treatment by helping to improve the safety and efficacy of novel therapeutic delivery vehicles. This paper reports the fabrication of poly(lactic acid-co-glycolic acid)/siRNA nanoparticles coated with lipids for use as prostate cancer therapeutics made via a unique soft lithography particle molding process called Particle Replication In Nonwetting Templates (PRINT). The PRINT process enables high encapsulation efficiency of siRNA into neutral and monodisperse PLGA particles (32-46% encapsulation efficiency). Lipid-coated PLGA/siRNA PRINT particles were used to deliver therapeutic siRNA in vitro to knockdown genes relevant to prostate cancer.
Related Papers
- → Dispersity in polymer science (IUPAC Recommendations 2009)(2009)306 cited
- → Precise Control of Both Dispersity and Molecular Weight Distribution Shape by Polymer Blending(2021)11 cited
- → Dispersity in polymer science (IUPAC Recommendation 2009)(2009)33 cited
- → Polydispersity in size-exclusion chromatography: A stochastic approach(2014)7 cited
- → The study of the polydispersity of polymers by viscometry(1960)24 cited